Free Trial

CorVel (CRVL) Competitors

CorVel logo
$81.59 -1.20 (-1.45%)
Closing price 04:00 PM Eastern
Extended Trading
$81.62 +0.03 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRVL vs. DVA, CHE, AMED, MD, AMN, CCRN, LH, DGX, APG, and RTO

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), and Rentokil Initial (RTO).

CorVel vs. Its Competitors

CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both mid-cap health care services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

51.4% of CorVel shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 44.6% of CorVel shares are owned by company insiders. Comparatively, 1.5% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CorVel has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.

CorVel has a net margin of 10.98% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat CorVel's return on equity.

Company Net Margins Return on Equity Return on Assets
CorVel10.98% 32.31% 18.33%
DaVita 6.35%369.39%4.62%

In the previous week, DaVita had 2 more articles in the media than CorVel. MarketBeat recorded 16 mentions for DaVita and 14 mentions for CorVel. DaVita's average media sentiment score of 0.70 beat CorVel's score of 0.64 indicating that DaVita is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CorVel
6 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DaVita
7 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

DaVita has a consensus target price of $158.00, indicating a potential upside of 21.52%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DaVita
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CorVel$895.59M4.68$95.17M$1.9442.07
DaVita$13.16B0.71$936.34M$10.1712.78

Summary

DaVita beats CorVel on 10 of the 15 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ Exchange
Market Cap$4.19B$5.61B$26.08B$10.26B
Dividend YieldN/A3.27%2.74%4.60%
P/E Ratio42.0727.7526.7526.53
Price / Sales4.682.051,070.33165.78
Price / Cash35.2516.0725.8729.90
Price / Book13.024.607.796.32
Net Income$95.17M$156.87M$197.70M$270.12M
7 Day Performance-6.78%-1.65%3.61%2.12%
1 Month Performance-7.48%-3.08%20.06%6.31%
1 Year Performance-23.73%51.68%49.51%25.51%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRVL
CorVel
2.0573 of 5 stars
$81.59
-1.4%
N/A-21.6%$4.19B$895.59M42.065,075
DVA
DaVita
4.6549 of 5 stars
$134.44
-2.5%
$164.00
+22.0%
-19.9%$9.86B$12.82B13.2276,000Analyst Upgrade
CHE
Chemed
4.9986 of 5 stars
$464.58
-0.2%
$592.25
+27.5%
-23.0%$6.79B$2.43B23.8915,695Positive News
Short Interest ↓
AMED
Amedisys
2.0457 of 5 stars
$101.01
+0.0%
$100.50
-0.5%
+4.2%$3.32B$2.40B39.3020,000
MD
Pediatrix Medical Group
2.3197 of 5 stars
$16.95
-0.7%
$16.79
-1.0%
+51.5%$1.49B$2.01B13.144,305Analyst Downgrade
AMN
AMN Healthcare Services
4.6274 of 5 stars
$20.97
+0.6%
$28.25
+34.7%
-61.4%$799.06M$2.98B-2.702,968Positive News
Short Interest ↓
CCRN
Cross Country Healthcare
3.5862 of 5 stars
$14.05
-0.4%
$17.93
+27.6%
-7.1%$461.94M$1.34B-54.048,205Positive News
LH
Labcorp
4.6486 of 5 stars
$276.99
-0.6%
$290.33
+4.8%
+24.5%$23.16B$13.01B30.5770,000Positive News
DGX
Quest Diagnostics
4.7755 of 5 stars
$182.53
-0.5%
$186.00
+1.9%
+17.1%$20.52B$9.87B21.8656,000Positive News
APG
APi Group
2.9603 of 5 stars
$35.16
+0.6%
$36.10
+2.7%
+53.6%$14.54B$7.02B109.8629,000News Coverage
Positive News
RTO
Rentokil Initial
1.5613 of 5 stars
$25.96
+1.6%
N/A+0.1%$12.91B$6.95B17.1968,485Positive News

Related Companies and Tools


This page (NASDAQ:CRVL) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners